Correction to: Measles virus hemagglutinin triggers intracellular signaling in CD150-expressing dendritic cells and inhibits immune response (Cellular & Molecular Immunology, (2016), 13, 6, (828-838), 10.1038/cmi.2015.55);Measles virus hemagglutinin triggers intracellular signaling in CD150-expressing dendritic cells and inhibits immune response

Cellular and Molecular Immunology

Volumn 13, Issue 6, 2016, Pages 828-838

  Romanets Korbut, Olga ^a,f   Kovalevska, Larysa M ^f   Seya, Tsukasa ^g   Sidorenko, Svetlana P ^f   Horvat, Branka ^a,b,c,d,e  

^a CENTRE INTERNATIONAL DE RECHERCHE EN INFECTIOLOGIE   (France)

^b INSERM   (France)

^c CNRS   (France)

^d UNIVERSITÉ LYON 1   (France)

^e UNIVERSITÉ DE LYON   (France)

^f R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

^g HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Dendritic cells; Measles virus; Signaling pathways; SLAM CD150

Indexed keywords

B7 ANTIGEN; CD150 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; VIRUS HEMAGGLUTININ; HEMAGGLUTININ;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DOWN REGULATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; INFLAMMATION; INTRACELLULAR SIGNALING; LYMPHOCYTE PROLIFERATION; MEASLES; MEASLES VIRUS; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; CELL LINE; IMMUNITY; IMMUNOLOGY; INTRACELLULAR SPACE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; DENDRITIC CELLS; HEMAGGLUTININS; HUMANS; IMMUNITY; INFLAMMATION; INTRACELLULAR SPACE; MEASLES VIRUS; MICE, INBRED C57BL; MODELS, BIOLOGICAL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHENOTYPE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SIGNALING LYMPHOCYTIC ACTIVATION MOLECULE FAMILY MEMBER 1;

EID: 84994633942     PISSN: 16727681     EISSN: 20420226     Source Type: Journal    
DOI: 10.1038/s41423-019-0332-z     Document Type: Erratum

References (60)

1. Perry RT, Gacic-Dobo M, Dabbagh A et al. Global control and regional elimination of measles, 2000-2012. MMWR Morb Mortal Wkly Rep 2014; 63: 103-107.
2. Moss WJ, Griffin DE. Measles. Lancet 2012; 379: 153-164.
3. De Swart RL, Ludlow M, de Witte L et al. Predominant infection of CD1501 lymphocytes and dendritic cells during measles virus infection of macaques. PLoS Pathog 2007; 3: e178.
4. Grosjean I, Caux C, Bella C et al. Measles virus infects human dendritic cells and blocks their allostimulatory properties for CD41 T cells. J Exp Med 1997; 186: 801-812.
5. Schnorr JJ, Xanthakos S, Keikavoussi P, Kampgen E, ter Meulen V, Schneider-Schaulies S. Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression, Proc Natl Acad Sci U S A 1997; 94: 5326-5331.
6. Fugier-Vivier I, Servet-Delprat C, Rivailler P, Rissoan MC, Liu YJ, Rabourdin-Combe C. Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J Exp Med 1997; 186: 813-823.
7. Takaki H, Oshiumi H, Matsumoto M, Seya T. Dendritic cell subsets involved in type I IFN induction in mouse measles virus infection models. Int J Biochem Cell Biol 2014; 53C: 329-333.
8. McChesney MB, Altman A, Oldstone MB. Suppression of T lymphocyte function by measles virus is due to cell cycle arrest in G1. J Immunol 1988; 140: 1269-1273.
9. Naniche D, Reed SI, Oldstone MB. Cell cycle arrest during measles virus infection: a G0-like block leads tosuppressionof retinoblastoma protein expression. J Virol 1999; 73: 1894-1901.
10. de Witte L, Abt M, Schneider-Schaulies S, van Kooyk Y, Geijtenbeek TB. Measles virus targets DC-SIGN to enhance dendritic cell infection. J Virol 2006; 80: 3477-3486.
11. Mesman AW, Zijlstra-Willems EM, Kaptein TM et al. Measles virus suppresses RIG-I-like receptor activation in dendritic cells via DC-SIGN-mediated inhibition of PP1 phosphatases, Cell Host Microbe 2014; 16: 31-42.
12. Naniche D, Varior-Krishnan G, Cervoni F et al. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 1993; 67: 6025-6032.
13. Dorig RE, Marcil A, Chopra A, Richardson CD. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 1993; 75: 295-305.
14. Tatsuo H, Ono N, Tanaka K, Yanagi Y. SLAM (CDw150) is a cellular receptor for measles virus. Nature 2000; 406: 893-897.
15. Muhlebach MD, Mateo M, Sinn PL et al. Adherens junction protein nectin-4 is the epithelial receptor for measles virus. Nature 2011; 480: 530-533.
16. Noyce RS, Bondre DG, Ha MN et al. Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus. PLoS Pathog 2011; 7: e1002240.
17. Cocks BG, Chang CC, Carballido JM, Yssel H, de Vries JE, Aversa G. A novel receptor involved in T-cell activation. Nature 1995; 376: 260-263.
18. Sidorenko SP, Clark EA. The dual-function CD150 receptor subfamily: the viral attraction. Nat Immunol 2003; 4: 19-24.
19. Wang N, Satoskar A, Faubion W et al. The cell surface receptor SLAM controls T cell and macrophage functions. J Exp Med 2004; 199: 1255-1264.
20. Howie D, Okamoto S, Rietdijk S, et al. The role of SAP in murine CD150 (SLAM)-mediated T-cell proliferation and interferon gamma production. Blood 2002; 100: 2899-2907.
21. Latour S, Gish G, Helgason CD, Humphries RK, Pawson T, Veillette A. Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product. Nat Immunol 2001; 2: 681-690.
22. Mikhalap SV, Shlapatska LM, Yurchenko OV et al. The adaptor protein SH2D1A regulates signaling through CD150 (SLAM)in B cells. Blood 2004; 104: 4063-4070.
23. Yurchenko M, Shlapatska LM, Romanets OL et al. CD150-mediated Akt signalling pathway in normal and malignant B cells. Exp Oncol 2011; 33: 9-18.
24. Yurchenko MY, Kovalevska LM, Shlapatska LM, Berdova GG, Clark EA, Sidorenko SP. CD150 regulates JNK1/2 activation in normal and Hodgkin'slymphoma B cells.Immunol Cell Biol 2010;88: 565-574.
25. Cannons JL, Tangye SG, Schwartzberg PL. SLAM family receptors and SAP adaptors in immunity. Annu Rev Immunol 2011; 29: 665-705.
26. Kerdiles YM, Sellin CI, Druelle J, Horvat B. Immunosuppression caused by measles virus: role of viral proteins. Rev Med Virol 2006; 16: 49-63.
27. Kouomou DW, Wild TF. Adaptationofwild-type measles virustotissue culture. J Virol 2002; 76: 1505-1509.
28. Schnell MJ, Buonocore L, Kretzschmar E, Johnson E, Rose JK. Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles. Proc Natl Acad Sci U S A 1996; 93: 11359-11365.
29. Naniche D, Wild TF, Rabourdin-Combe C, Gerlier D. A monoclonal antibody recognizes a human cell surface glycoprotein involved in measles virus binding. J Gen Virol 1992; 73: 2617-2624.
30. Giraudon P, Wild TF. Correlation between epitopes on hemagglutinin of measles virus and biological activities: passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity. Virology 1985; 144: 46-58.
31. Shingai M, Inoue N, Okuno T et al. Wild-type measles virus infection in human CD46/CD150-transgenic mice: CD11c-positive dendritic cells establish systemic viral infection.J Immunol 2005; 175: 3252-3261.
32. Marie JC, Astier AL, Rivailler P, Rabourdin-Combe C, Wild TF, Horvat B. Linking innate and acquired immunity: divergent role of CD46 cytoplasmic domains in T cell induced inflammation. Nat Immunol 2002; 3: 659-666.
33. Avota E, Avots A, Niewiesk S et al. Disruption of Akt kinase activation is important for immunosuppression induced by measles virus. Nat Med 2001; 7: 725-731.
34. Marie JC, Kehren J, Trescol-Biemont MC et al. Mechanism of measles virus-induced suppression of inflammatory immune responses. Immunity 2001; 14: 69-79.
35. Marie JC, Saltel F, Escola JM, Jurdic P, Wild TF, Horvat B. Cell surface delivery of the measles virus nucleoprotein: a viral strategy to induce immunosuppression. J Virol 2004; 78: 11952-11961.
36. Bieback K, Lien E, Klagge IM et al. Hemagglutinin proteinofwild-type measles virus activates toll-like receptor 2 signaling. J Virol 2002; 76: 8729-8736.
37. Geijtenbeek TB, Torensma R, van Vliet SJ et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000; 100: 575-585.
38. Nakahara T, Moroi Y, Uchi H, Furue M. Differential role of MAPK signaling in human dendritic cell maturation and Th1/Th2 engagement. J Dermatol Sci 2006; 42: 1-11.
39. Caparrós E, Munoz P, Sierra-Filardi E et al. DC-SIGN ligation on dendritic cells results in ERK and PI3K activation and modulates cytokine production. Blood 2006; 107: 3950-3958.
40. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003; 3: 133-146.
41. Grabbe S, Schwarz T. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol Today 1998; 19: 37-44.
42. Tamashiro VG, Perez HH, Griffin DE. Prospective study of the magnitude and duration of changes in tuberculin reactivity during uncomplicated and complicated measles. Pediatr Infect Dis J 1987; 6: 451-454.
43. De Witte L, De Vries RD, Van Der Vlist M et al. DC-SIGN and CD150 have distinct roles in transmission of measles virus from dendritic cells to T-lymphocytes. PLoS Pathog 2008; 4: e1000049.
44. Murabayashi N, Kurita-Taniguchi M, Ayata M, Matsumoto M, Ogura H, Seya T. Susceptibility of human dendritic cells (DCs) to measles virus (MV) depends on their activation stages in conjunction with the level of CDw150: role of Toll stimulators in DC maturation and MV amplification. Microbes Infect 2002; 4: 785-794.
45. Hahm B, Arbour N, Oldstone MB. Measles virus interacts with human SLAM receptor on dendritic cells to cause immunosuppression. Virology 2004; 323: 292-302.
46. Rethi B, Gogolak P, Szatmari I et al. SLAM/SLAM interactions inhibit CD40-induced production of inflammatory cytokines in monocyte-derived dendritic cells. Blood 2006; 107: 2821-2829.
47. Qeska V, Barthel Y, Herder V et al. Canine distemper virus infection leads to an inhibitory phenotype of monocyte-derived dendritic cells in vitro with reduced expression of co-stimulatory molecules and increased interleukin-10 transcription. PLoS One 2014; 9: e96121.
48. Atabani SF, Byrnes AA, Jaye A et al. Natural measles causes prolonged suppression of interleukin-12 production. J Infect Dis 2001; 184: 1-9.
49. Polack FP, Hoffman SJ, Moss WJ, Griffin DE. Altered synthesis of interleukin-12 and type 1 and type 2 cytokinesin rhesus macaques during measles and atypical measles. J Infect Dis 2002; 185: 13-19.
50. Hahm B, Cho JH, Oldstone MB. Measles virus-dendritic cell interaction via SLAM inhibits innate immunity: selective signaling through TLR4 but not other TLRs mediates suppression of IL-12 synthesis. Virology 2007; 358: 251-257.
51. Karp CL, Wysocka M, Wahl LM et al. Mechanism of suppression of cell-mediated immunity by measles virus. Science 1996; 273: 228-231.
52. Waggoner SN, Cruise MW, Kassel R, Hahn YS. gC1q receptor ligation selectively down-regulates human IL-12 production through activation of the phosphoinositide 3-kinase pathway. J Immunol 2005; 175: 4706-4714.
53. Martínez D, Vermeulen M, von Euw E et al. Extracellular acidosis triggers the maturation of human dendritic cells and the production of IL-12. J Immunol 2007; 179: 1950-1959.
54. Arrighi J, Rebsamen M, Rousset F, Kindler V, Hauser C. A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-alpha, and contact sensitizers. J Immunol 2001; 166: 3837-3845.
55. Hirsch RL, Griffin DE, Johnson RT et al. Cellular immune responses during complicated and uncomplicated measles virus infections in man. Clin Immunol Immunopathol 1984; 31: 1-12.
56. Ward BJ, Griffin DE. Changes in cytokine production after measles virus vaccination: predominant production of IL-4 suggests induction of a Th2 response.Clin Immunol Immunopathol 1993; 67: 171-177.
57. Hahm B, Arbour N, Naniche D, Homann D, Manchester M, Oldstone MB. Measles virus infects and suppresses proliferation of T lymphocytes from transgenic mice bearing human signaling lymphocytic activation molecule. J Virol 2003; 77: 3505-3515.
58. Yu XL, Cheng YM, Shi BS et al. Measles virus infection in adults induces production of IL-10 and is associated with increased CD41 CD251 regulatory T cells. J Immunol 2008; 181: 7356-7366.
59. Sellin CI, Jégou J, Renneson J et al. Interplay between virus-specific effector response and Foxp3 regulatory T cells in measles virus immunopathogenesis. PLoS One 2009; 4: e4948.
60. de Vries RD, McQuaid S, van Amerongen G et al. Measles immune suppression: lessons from the macaque model. PLoS Pathog 2012;8: e1002885.